ID-8 is an inhibitor of DYRK inhibitor that can sustain embryonic stem cell self-renewal and survival without differentiation.


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 靶点 |
|
| 描述 | The dual-specificity tyrosine-phosphorylation-regulated (DYRK) kinases belong to a family collectively referred to as CMGC kinases that includes cyclin dependent kinases, mitogen associated protein kinases, glycogen synthase kinases, and cyclin dependent-like kinases. ID-8, a DYRK inhibitor, shows high specificity for DYRK1A and DYRK1B with IC50s of 78 and 54 nM, respectively[3]. ID-8 increased hESC (human embryonic stem cells) survival (∼1.1% at 0.5 μM). The combination of Wnt3a and ID-8 further increased survival (∼1.7%) and completely prevented Wnt-induced differentiation morphologically without disrupting proliferation. Wnt-induced differentiation marker gene expression was dramatically reduced by ID-8 at a dose that maintained the undifferentiated state[4]. Treatment with ID-8 (10 µM) promoted significant increases in cell number after 24 hours of damage in at least two different damage models[5]. |
| Concentration | Treated Time | Description | References | |
| ID-8 cells | 0, 1.2, 2.4, 4.8, 9.6 μg/mL | 24 hours | To evaluate the effect of Tanshinone IIA on VEGF and COX2 mRNA expression in ID-8 cells, results showed that Tanshinone IIA significantly inhibited VEGF and COX2 mRNA expression. | Ann Transl Med. 2020 Oct;8(20):1295 |
| ID-8 cells | 0, 1.2, 2.4, 4.8, 9.6 μg/mL | 24 hours | To evaluate the effect of Tanshinone IIA on the migration of ID-8 cells, results showed that Tanshinone IIA significantly inhibited cell migration. | Ann Transl Med. 2020 Oct;8(20):1295 |
| ID-8 cells | 0, 1.2, 2.4, 4.8, 9.6 μg/mL | 24 hours | To evaluate the effect of Tanshinone IIA on the apoptosis of ID-8 cells, results showed that Tanshinone IIA significantly upregulated Bax mRNA expression and downregulated Bcl-2 mRNA expression, promoting apoptosis. | Ann Transl Med. 2020 Oct;8(20):1295 |
| ID-8 cells | 0, 1.2, 2.4, 4.8, 9.6 μg/mL | 24 hours | To evaluate the effect of Tanshinone IIA on the proliferation of ID-8 cells, results showed that Tanshinone IIA significantly inhibited the proliferation of ID-8 cells in a dose-dependent manner. | Ann Transl Med. 2020 Oct;8(20):1295 |
| ID-8 cells | 1000 nM | 6 hours (migration) and 16 hours (invasion) | To evaluate the effect of DEX on cell migration and invasion abilities, results showed that DEX significantly reduced the migration and invasion abilities of ID-8 cells, and this inhibition could be abrogated by depletion of endogenous miR-708 | PLoS One. 2017 Jun 7;12(6):e0178937 |
| ID-8 cells | 100-1000 nM | 48 hours | To evaluate the effect of DEX on Rap1B expression, results showed that DEX reduced Rap1B expression | PLoS One. 2017 Jun 7;12(6):e0178937 |
| ID-8 cells | 100-1000 nM | 72 hours | To evaluate the effect of DEX on miR-708 expression, results showed that DEX significantly induced miR-708 expression | PLoS One. 2017 Jun 7;12(6):e0178937 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.35mL 0.67mL 0.34mL |
16.76mL 3.35mL 1.68mL |
33.52mL 6.70mL 3.35mL |
|
| CAS号 | 147591-46-6 |
| 分子式 | C16H14N2O4 |
| 分子量 | 298.29 |
| SMILES Code | OC1=CC2=C(C=C1)C([N+]([O-])=O)=C(C)N2C3=CC=C(OC)C=C3 |
| MDL No. | MFCD00593367 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | VVZNWYXIOADGSW-UHFFFAOYSA-N |
| Pubchem ID | 791637 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 45 mg/mL(150.86 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1